Karoline Laske

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Markus Löffler, P. Anoop Chandran, Karoline Laske et al. · Journal of Hepatology · 2016 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P. Anoop Chandran et al. · Journal for ImmunoTherapy of Cancer · 2019 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

Lindsey Chudley, Katy J. McCann, Adam Coleman et al. · Cancer Immunology Immunotherapy · 2014 · 38 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases

Steffen Rausch, Cécile Gouttefangeas, Jörg Hennenlotter et al. · European Urology Focus · 2017 · 26 citations

Medicine, Immunology, Oncology +14

Cryopreservation of <scp>MHC</scp> multimers: Recommendations for quality assurance in detection of antigen specific <scp>T</scp> cells

Sine Reker Hadrup, Dominik Maurer, Karoline Laske et al. · Cytometry Part A · 2014 · 22 citations · Full text

Life Sciences, Biotechnology, Immunology +17